Submitted by Anonymous (not verified) on 2 October 2024 - 12:20
Opinion/decision on a Paediatric investigation plan (PIP): Eliquis, Apixaban, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiovascular diseases, PIP number: P/0338/2023
Source: